Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-176464
Filing Date
2024-07-08
Accepted
2024-07-08 21:42:58
Documents
2
Group Members
ATHYRIUM FUNDS GP HOLDINGS LLCATHYRIUM OPPORTUNITIES 2020 LPATHYRIUM OPPORTUNITIES ASSOCIATES CO-INVEST LLCATHYRIUM OPPORTUNITIES ASSOCIATES III GP LLCATHYRIUM OPPORTUNITIES ASSOCIATES III LPATHYRIUM OPPORTUNITIES III ACQUISITION 2 LPATHYRIUM OPPORTUNITIE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d854123dsc13da.htm SC 13D/A 228744
2 EX-99.20 d854123dex9920.htm EX-99.20 127289
  Complete submission text file 0001193125-24-176464.txt   358256
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Subject) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91551 | Film No.: 241106213
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017
Business Address 505 FIFTH AVENUE, FLOOR 18 NEW YORK NY 10017 646-434-1636
Athyrium Opportunities III Co-Invest 1 LP (Filed by) CIK: 0001815260 (see all company filings)

EIN.: 821097086 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A